IPO Trending
CHEMCONEQ / NSE, BSEListed

Chemcon Speciality Chemicals Limited

Chemcon Speciality Chemicals Ltd, incorporated in 1988, is engaged in the manufacturing of specialised chemicals such as HMDS and CMIC, along with oilfield chemicals including calcium bromide, sodium bromide, and zinc bromide, pharma intermediates, silanes, and contract manufacturing services. Pharmaceutical chemicals form the largest part of its revenue, with key customers comprising Hetero Labs, Laurus Labs, Aurobindo Pharma, Lantech Pharmaceuticals, and Macleods Pharma, while in the oilfield chemicals segment it caters to clients like Shree Radha Overseas, Universal Drilling Fluids, and Water Systems Speciality. In 2018, the company ranked as the eighth-largest HMDS manufacturer and the second-largest CMIC manufacturer globally, highlighting its strong market position. Chemcon serves both domestic and international markets, exporting to countries such as the USA, China, Japan, UAE, Serbia, Russia, Malaysia, and Azerbaijan, and operates its manufacturing facility at Manjusar near Vadodara, Gujarat, which includes five production plants, three owned warehouses, and two leased warehouses.

₹338 - ₹340149.3x sub
Listed Price731.00
Listing Gain+115.00%
TimelineBookbuilding IPO
Open21 Sep 2020
Close23 Sep 2020
Allotment29 Sep 2020
Listing01 Oct 2020

Quota Reservation Portions

RetailPortion: 32,83,580 shares
35.11%
Nii(hni)Portion: 14,07,249 shares
15.05%
QIBPortion: 18,68,344 shares
19.98%

Minimum Application Bracket Matrix

Retail1 lots / 44 shares
₹14,960
sHNI14 lots / 616 shares
₹2,09,440
bHNI67 lots / 2,948 shares
₹10,02,320

About the Company

Chemcon Speciality Chemicals Ltd, incorporated in 1988, is engaged in the manufacturing of specialised chemicals such as HMDS and CMIC, along with oilfield chemicals including calcium bromide, sodium bromide, and zinc bromide, pharma intermediates, silanes, and contract manufacturing services. Pharmaceutical chemicals form the largest part of its revenue, with key customers comprising Hetero Labs, Laurus Labs, Aurobindo Pharma, Lantech Pharmaceuticals, and Macleods Pharma, while in the oilfield chemicals segment it caters to clients like Shree Radha Overseas, Universal Drilling Fluids, and Water Systems Speciality. In 2018, the company ranked as the eighth-largest HMDS manufacturer and the second-largest CMIC manufacturer globally, highlighting its strong market position. Chemcon serves both domestic and international markets, exporting to countries such as the USA, China, Japan, UAE, Serbia, Russia, Malaysia, and Azerbaijan, and operates its manufacturing facility at Manjusar near Vadodara, Gujarat, which includes five production plants, three owned warehouses, and two leased warehouses.

Company Promoters

KamalKumar Rajendra AggarwalNavdeep Naresh GoyalShubharangana Goyal